EXPANDING ACCESS TO QUALITY, AFFORDABLE MEDICATION
Live / Allowed — Notice of allowance issued (as of 21 Oct 2025)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 03 Sept 2024 filing date already counts against anyone who files later.
Record
- Serial number
- 98729743
- Mark type
- Stylized text
- Filed
- 03 Sept 2024
- Published for opposition
- 26 Aug 2025
- Attorney of record
- John A. Yates
Goods and services
- Class 035 — Advertising and business services: Supply chain management services in the field of pharmaceuticals
- Class 042 — Scientific and technological services: Pharmaceutical drug development services and contract pharmaceutical drug development services; Research and development services of pharmaceutical products and preparations; Research and development services of pharmaceutical products and preparations for others; Conducting pharmaceutical research, pharmaceutical drug formulation development, scientific research in the nature of conducting clinical trials for others, commercial production in the nature of pharmaceutical products development, packaging design, and quality assurance for others in the pharmaceutical industry in the field of pharmaceuticals; Conducting post-marketing product support for others in the pharmaceutical industry in the field of pharmaceuticals, namely, post-market surveillance in the nature of pharmaceutical product evaluation, scientific research in the nature of conducting clinical trials for others, and pharmaceutical research studies to further assess the safety, efficacy, or optimal use of approved products; Laboratory research services and contract research services, namely, analytical and microbiological testing for others in the pharmaceutical industry; Research laboratory analysis for others in the field of pharmaceuticals; Scientific laboratory services in the fields of pharmacology, microbiology, toxicology, and biotechnology; Testing and analysis of pharmaceuticals per industry standards and for compliance with the requirements of the United States Pharmacopeia regulatory requirements; Quality control testing for others in the pharmaceutical industry; Quality management services, namely, quality evaluation and analysis, quality assurance, and quality control, in the fields of pharmacology, microbiology, toxicology, and biotechnology; Testing of pharmaceutical raw materials to determine conformity with established regulatory standards
- Class 045 — Legal and security services: Regulatory compliance consulting in the field of pharmaceuticals
Owner
- Empower Clinic Services, L.L.C., Houston, TX, US
- Empower Clinic Services, L.L.C., Houston, TX, US
Prosecution history
- 21 Oct 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 26 Aug 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 26 Aug 2025 — PUBLISHED FOR OPPOSITION
- 20 Aug 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 22 Jul 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 22 Jul 2025 — EXAMINER'S AMENDMENT ENTERED
- 22 Jul 2025 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 22 Jul 2025 — EXAMINERS AMENDMENT E-MAILED
- 22 Jul 2025 — EXAMINERS AMENDMENT -WRITTEN
- 19 Jun 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 19 Jun 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 19 Jun 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 07 Apr 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 07 Apr 2025 — NON-FINAL ACTION E-MAILED
- 07 Apr 2025 — NON-FINAL ACTION WRITTEN